Aflunov

Aflunov is a vaccine designed to protect against the H5N1 influenza strain. It is administered intramuscularly and is manufactured by Seqirus S.R.L. in the EU. This vaccine is intended for use in preventing influenza caused by the H5N1 virus.

Aflunov is used to provide immunity against the H5N1 influenza strain, commonly known as avian flu. It is typically administered to individuals who are at risk of exposure to this particular strain of the virus. The vaccine works by stimulating the body's immune response to develop protection against the H5N1 influenza virus.

Common effects of Aflunov may include mild soreness or redness at the injection site. Some individuals might experience temporary discomfort, fatigue, or low-grade fever following vaccination. These effects are generally mild and short-lived.

Aflunov should be stored and handled according to the manufacturer's guidelines to maintain its efficacy. It is important to inform healthcare providers about any allergies or medical conditions before receiving the vaccine. Individuals with a history of severe allergic reactions to vaccines should exercise caution.

Aflunov may interact with certain medications or other vaccines. It is advisable to consult with a healthcare provider before receiving Aflunov if you are taking other medications or have recently received other vaccines. Alcohol and other substances may not directly interact with Aflunov but can affect overall health and immune response.